Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Food & Function

• Publication date

  2018-03-21

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1039/c7fo01528cPMID 29485654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator‐blinded, active‐controlled trial and a phase III, multicenter, open trial

  2018cited by this paper
• Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation

  2017cited by this paper
• Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

  2017cited by this paper
• Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

  2017cited by this paper
• The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review

  2017cited by this paper
• Probiotics for people with hepatic encephalopathy.

  2017cited by this paper
• The animal naming test: An easy tool for the assessment of hepatic encephalopathy

  2017cited by this paper
• Gut microbiome and liver disease.

  2017cited by this paper
• Probiotics and prebiotics in Crohn's disease therapies.

  2016cited by this paper
• Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides

  2016cited by this paper
• Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta‐analysis

  2016cited by this paper
• Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia

  2016cited by this paper
• Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis

  2016cited by this paper
• Neurotoxicity of Ammonia

  2016cited by this paper
• Fecal microbiota transplantation in the management of hepatic encephalopathy

  2016cited by this paper
• Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice

  2016cited by this paper
• Probiotics in management of hepatic encephalopathy

  2016cited by this paper
• Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis

  2016cited by this paper
• Microbe-host interactions: Influence of the gut microbiota on the enteric nervous system.

  2016cited by this paper
• Probiotics and prebiotics in ulcerative colitis.

  2016cited by this paper
• Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition

  2016cited by this paper
• Probiotics are helpful in hepatic encephalopathy: a meta‐analysis of randomized trials

  2016cited by this paper
• Ammonia toxicity: from head to toe?

  2016cited by this paper
• Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non‐inferiority randomized controlled trial

  2015cited by this paper
• Serotonin, tryptophan metabolism and the brain-gut-microbiome axis.

  2015cited by this paper
• Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited

  2015cited by this paper
• Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children.

  2015cited by this paper
• Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Gut Microbiota, Cirrhosis, and Alcohol Regulate Bile Acid Metabolism in the Gut

  2015cited by this paper
• Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver

  2015cited by this paper
• Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease

  2015cited by this paper
• Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

  2015cited by this paper
• Gut microbiota and host metabolism in liver cirrhosis.

  2015cited by this paper
• Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health.

  2015cited by this paper
• Gut-liver axis in alcoholic liver disease.

  2015cited by this paper
• Definition and nomenclature of hepatic encephalopathy.

  2015cited by this paper
• Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis.

  2015cited by this paper
• Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy

  2015cited by this paper
• Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

  2015cited by this paper
• VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride‐induced cirrhosis

  2015cited by this paper
• Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.

  2015cited by this paper
• Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases.

  2015cited by this paper
• Probiotics in Pediatric Liver Disease

  2015cited by this paper
• Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

  2014cited by this paper
• Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry

  2014cited by this paper
• Altered profile of human gut microbiome is associated with cirrhosis and its complications.

  2014cited by this paper
• Interactions between the intestinal microbiome and liver diseases.

  2014cited by this paper
• The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90‐day and 1‐year mortality

  2014cited by this paper
• Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy.

  2014cited by this paper
• The role of microbiota in hepatic encephalopathy

  2014cited by this paper
• Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

  2014cited by this paper
• Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System

  2014cited by this paper
• Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.

  2014cited by this paper
• The Gut Microbiome and the Brain

  2014cited by this paper
• Pathological bacterial translocation in liver cirrhosis.

  2014cited by this paper
• Immune dysfunction in cirrhosis.

  2014cited by this paper
• Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

  2014cited by this paper
• Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

  2014cited by this paper
• Gut microbiota and metabolic syndrome.

  2014cited by this paper
• Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

  2014cited by this paper
• Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship

  2014cited by this paper
• Altered brain‐gut axis in autism: Comorbidity or causative mechanisms?

  2014cited by this paper
• Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.

  2014cited by this paper
• Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites

  2014cited by this paper
• Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy

  2014cited by this paper
• Autoimmunity and the Gut

  2014cited by this paper
• Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed

  2014cited by this paper
• Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

  2014cited by this paper
• Alterations of the human gut microbiome in liver cirrhosis

  2014cited by this paper
• Microbiome Composition by Pyrosequencing in Mesenteric Lymph Nodes of Rats with CCl4-Induced Cirrhosis

  2013cited by this paper
• Sensitization of Peripheral Sensory Nerves by Mediators From Colonic Biopsies of Diarrhea-Predominant Irritable Bowel Syndrome Patients: A Role for PAR2

  2013cited by this paper
• Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications

  2013cited by this paper
• The gut-liver axis

  2013cited by this paper
• The gut microbiota and the liver. Pathophysiological and clinical implications.

  2013cited by this paper
• Altered colonic function and microbiota profile in a mouse model of chronic depression

  2013cited by this paper
• Gut microbiota and hepatic encephalopathy

  2013cited by this paper
• Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

  2013cited by this paper
• A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy

  2013cited by this paper
• Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature

  2013cited by this paper
• Antibiotics for the treatment of hepatic encephalopathy

  2013cited by this paper
• Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.

  2013cited by this paper
• Cirrhosis, bile acids and gut microbiota

  2013cited by this paper
• VSL#3® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis

  2013cited by this paper
• Large-Scale Survey of Gut Microbiota Associated With MHE Via 16S rRNA-Based Pyrosequencing

  2013cited by this paper
• Immune Activation in Irritable Bowel Syndrome: Can Neuroimmune Interactions Explain Symptoms?

  2013cited by this paper
• Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial

  2013cited by this paper
• Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

  2013cited by this paper
• Gut microbiota, enteroendocrine functions and metabolism.

  2013cited by this paper
• Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration.

  2013cited by this paper
• Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy

  2013cited by this paper
• Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.

  2013cited by this paper
• The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury

  2013cited by this paper
• Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

  2013cited by this paper
• Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

  2013cited by this paper
• Psychobiotics: a novel class of psychotropic.

  2013cited by this paper
• Synbiotic formulation of probiotic and lactulose combination for hepatic encephalopathy treatment: a realistic hope?

  2013cited by this paper
• Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

  2012cited by this paper
• Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.

  2012cited by this paper
• Intestinal microbiota in functional bowel disorders: a Rome foundation report

  2012cited by this paper
• Voices from within: gut microbes and the CNS

  2012cited by this paper

• Leonurine alleviates HFD-induced inflammation and dyslipidemia via modulating gut microbiota-derived indole-3-propionic acid signaling.

  2026cites this paper
• Serotonin, Kynurenine, and Indole Pathways of Tryptophan Metabolism in Humans in Health and Disease

  2026cites this paper
• Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities.

  2026cites this paper
• Advances in understanding, diagnosing, and treating hepatic encephalopathy: from epidemiology to emerging therapies.

  2026cites this paper
• Research progress on the role and mechanism of traditional Chinese medicine based on "liver-multiple-organ interaction".

  2026cites this paper
• Exploring the Complexities of Hepatic Encephalopathy: Pathophysiology and Innovative Therapeutic Options

  2025cites this paper
• The analysis of the gut microbiome during liver disease progression led to the identification of biomarkers for related mild cognitive impairment

  2025cites this paper
• Zingibroside R1 Isolated From Achyranthes bidentata Blume Ameliorates LPS/D‐GalN‐Induced Liver Injury by Regulating Succinic Acid Metabolism via the Gut Microbiota

  2025cites this paper
• Unraveling the Gut–Liver–Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches

  2025cites this paper
• Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions

  2025cites this paper
• Clinical and biological significance of the relationship between gut microbiota and liver disease

  2025cites this paper
• Association between mental health and MASLD molecular insights through metabolomics

  2025cites this paper
• Gut microbiota in hepatic encephalopathy: a 3PM-guided three-tier health strategy

  2025cites this paper
• Targeting gut microbiota in liver disease: A pharmacological approach for hepatic encephalopathy and beyond

  2025cites this paper
• How the gut-liver axis shapes hepatic encephalopathy: mechanistic and therapeutic perspectives

  2025cites this paper
• Liver Diseases and Brain Disorders: Genetic Mechanisms and Biomarker Pathways in a Prospective Cohort Study From the UK Biobank

  2025cites this paper
• The gut–brain axis underlying hepatic encephalopathy in liver cirrhosis

  2025cites this paper
• Isolation of Calenduloside E from Achyranthes bidentata Blume and its effects on LPS/D-GalN-induced acute liver injury in mice by regulating the AMPK-SIRT3 signaling pathway.

  2024cites this paper
• Effects of Metabolic Dysfunction–Associated Steatohepatitis in Alertness, Associative Learning, and Astrocyte Density

  2024cites this paper
• Recent insights into contributing factors in the pathogenesis of cirrhotic ascites

  2024cites this paper
• The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis

  2024cites this paper
• Converging neural-centric and mechano-regulation in organoid modeling for system biology and medicine

  2024cites this paper
• Understanding and role of gut microbiota on drug response and toxicity

  2024cites this paper
• Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update

  2024cites this paper
• Homeostatic crosstalk among gut microbiome, hypothalamic and hepatic circadian clock oscillations, immunity and metabolism in response to different light–dark cycles: A multiomics study

  2023cites this paper
• Gut microbiota associated with appetite suppression in high-temperature and high-humidity environments

  2023cites this paper
• From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes

  2023cites this paper
• Acetobacter pasteurianus BP2201 alleviates alcohol‐induced hepatic and neuro‐toxicity and modulate gut microbiota in mice

  2023cites this paper
• Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease

  2023cites this paper
• Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota

  2023cites this paper
• The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis

  2023cites this paper
• Hepatic Encephalopathy in Cirrhotic Patients and Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis

  2022cites this paper
• Application of Bone Marrow Mesenchymal Stem Cells Effectively Eliminates Endotoxemia to Protect Rat from Acute Liver Failure Induced by Thioacetamide

  2022cites this paper
• Chronic exposure to ambient traffic-related air pollution (TRAP) alters gut microbial abundance and bile acid metabolism in a transgenic rat model of Alzheimer’s disease

  2022cites this paper
• Varied Composition and Underlying Mechanisms of Gut Microbiome in Neuroinflammation

  2022cites this paper
• Superior cervical ganglionectomy alters gut microbiota in rats.

  2022cites this paper
• Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1.

  2022cites this paper
• SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies

  2022cites this paper
• A meta-analysis of the association between Helicobacter pylori infection and risk of hepatic encephalopathy.

  2022cites this paper
• The gut–microbiota–brain changes across the liver disease spectrum

  2022cites this paper
• Targets of statins intervention in LDL-C metabolism: Gut microbiota

  2022cites this paper
• Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap

  2022cites this paper
• Chitooligosaccharides attenuated hepatic encephalopathy in mice through stabilizing gut-liver-brain disturbance.

  2022cites this paper
• Changes in Gut Microbiota Structure: A Potential Pathway for Silver Nanoparticles to Affect the Host Metabolism.

  2022cites this paper
• Host-microbiome interactions: Gut-Liver axis and its connection with other organs

  2022cites this paper
• Contribution of gut microbiomes and their metabolomes to the performance of Dorper and Tan sheep

  2022cites this paper
• Effects of different foxtail millet addition amounts on the cognitive ability of mice

  2022cites this paper
• Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption

  2021cites this paper
• A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy

  2021cites this paper
• Organ-organ communication: The liver's perspective

  2021cites this paper
• Quality of life indicators in hepatic encephalopathy following supplementation with branched chain amino acids and/or synbiotics: A post‐hoc analysis

  2021cites this paper
• The gut–liver–brain axis: dietary and therapeutic interventions

  2021cites this paper
• Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives

  2021cites this paper
• Predictive Value of Blood Ammonia in the Prognosis of Acute Liver Failure Evaluated by Receiver Operating Characteristic Curves.

  2021cites this paper
• Connecting the dots: Targeting the microbiome in drug toxicity

  2021influential citation
• Therapeutic modulation methods of gut microbiota and gut-liver axis

  2021cites this paper
• Dietary Polyphenols to Combat Nonalcoholic Fatty Liver Disease via the Gut-Brain-Liver Axis: A Review of Possible Mechanisms.

  2021cites this paper
• Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease

  2021cites this paper
• Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats

  2021cites this paper
• Genetically engineered E. coli Nissle attenuates hyperammonemia and prevents memory impairment in bile‐duct ligated rats

  2021cites this paper
• Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective

  2021cites this paper
• Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver

  2021cites this paper
• Transplantation of bone mesenchymal stem cells effectively promotes intestine regeneration to eliminate endotoxemia and reduce mortality in the animal model of acute liver failure

  2020cites this paper
• Akkermansia Muciniphila and Environmental Enrichment Reverse Cognitive Impairment Associated With High-fat High-cholesterol Consumption Through the Gut-brain Axis

  2020cites this paper
• Nonpharmacologic Management of Hepatic Encephalopathy: An Update.

  2020cites this paper
• Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease

  2020cites this paper
• Role of gut microbiota via the gut-liver-brain axis in digestive diseases

  2020cites this paper
• Nutrition and aging: is there a link to cognitive health?

  2020cites this paper
• Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling

  2020cites this paper
• Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship

  2019cites this paper
• Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis

  2019cites this paper
• Lycium ruthenicum diet alters the gut microbiota and partially enhances gut barrier function in male C57BL/6 mice

  2019cites this paper
• TLR5 silencing reduced hyperammonaemia-induced liver injury by inhibiting oxidative stress and inflammation responses via inactivating NF-κB and MAPK signals.

  2019cites this paper
• Evaluation of a Dual-Acting Antibacterial Agent, TNP-2092, on Gut Microbiota and Potential Application in the Treatment of Gastrointestinal and Liver Disorders.

  2019cites this paper
• Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure

  2019cites this paper
• Advanced Organ-on-a-Chip Devices to Investigate Liver Multi-Organ Communication: Focus on Gut, Microbiota and Brain

  2019cites this paper
• Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study

  2019cites this paper
• World Journal of Hepatology

  year unknowncites this paper
• World Journal of Hepatology

  year unknowncites this paper
• World Journal of Hepatology

  year unknowncites this paper